Newly Established Samsung Epis Holdings to Drive Growth for Samsung Bioepis and a New Subsidiary

Samsung Epis Holdings to be listed on Korea Exchange (KRX) on November 24, 2025 Samsung Epis Holdings to focus on exploring next-generation growth drivers and optimizing business strategies for its subsidiaries ‒Samsung Bioepis and a new company under Samsung Epis Holdings Samsung Bioepis will continue to operate its biosimilar business as a 100% owned subsidiary […]

Leave a Reply

Your email address will not be published. Required fields are marked *